Ultra-high Radiofrequency Hyperthermia is the fastest growing segment fueling the growth of Hyperthermia Cancer Treatment Market
Hyperthermia Cancer treatment Market |
The global Hyperthermia Cancer
Treatment Market is estimated to be valued at US$ 187.05 Bn or billion in 2023
and is expected to exhibit a CAGR of 6.1% over the forecast period from 2023 to
2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The hyperthermia cancer treatment
market involves the usage of heat therapy to destroy or reduce the size of
tumors. Heat therapy achieves this by damaging and killing cancer cells or
making them more sensitive to the effects of radiation and certain anti-cancer
drugs. This market utilizes heat treatments like radiofrequency hyperthermia
and microwave hyperthermia for tumor ablation.
Market key trends:
One of the key trends in the
hyperthermia cancer treatment market is the growing adoption of ultra-high
radiofrequency hyperthermia. Ultra-high frequencies ranging from 13.56 MHz to
100 MHz are being utilized to treat cancerous tumors localized in the body. The
higher frequencies allow for better penetration depth within tissues to destroy
tumors effectively. Research and development is ongoing to enhance the
utilization of ultra-high frequencies to treat cancers that were previously
difficult to treat with hyperthermia. Ongoing clinical research studies are
evaluating the safety and efficacy of ultra-high RF hyperthermia to tackle
cancers like those in the pancreas and lung. Along with localized therapy,
efforts are also examining its role in improving the efficacy of chemotherapy
and radiotherapy.
Segment Analysis
The global hyperthermia cancer
treatment market is segmented into two categories based on technology:
hyperthermia devices and hyperthermia disposables. The hyperthermia devices
segment dominates the market and is expected to continue its dominance over the
forecast period. This is because hyperthermia devices such as microwave hyperthermia
devices are used repeatedly to treat cancer, making them a worthwhile long-term
investment for hospitals and cancer treatment centers.
Key Takeaways
The Global
Hyperthermia Cancer Treatment Market Size is expected to witness high
growth, exhibiting a CAGR of 6.1% over the forecast period, due to increasing
cases of cancer worldwide.
North America dominates the
global hyperthermia cancer treatment market currently due to high awareness
regarding cancer treatment options and availability of advanced healthcare
facilities in the region. Europe holds the second largest share in the market
owing to rising healthcare expenditure and government support for cancer
treatment.
Key players operating in the hyperthermia cancer treatment market
are MagForce AG, Andromedic, Xianke Medical Equipment, OncoTherm, Celsius42+,
Oncotherm, Pyrexar Medical, Yamamoto Vinita, Nanoprobes, Alba Hyperthermia System,
Nova Company, Perseon, Omron, Sunny Medical Equipment, OrienTech, BSD Medical,
Sensius, Celsius42, Nanjing Greathope, Shanghai Huayuan. The global
hyperthermia cancer treatment market is growing owing to increasing adoption of
hyperthermia as an effective treatment for cancer worldwide.
Read more
https://www.dailyprbulletin.com/hyperthermia-cancer-treatment-market-size-share-growth-outlook-2023/
Comments
Post a Comment